Rezultaty - Axel Finckh
- Rezultaty 1 - 20 Rezultaty od 55
- Idź do następnej strony
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
Comparative Efficacy of Novel DMARDs as Monotherapy and in Combination with Methotrexate in Rheumatoid Arthritis Patients with Inadequate Response to Conventional DMARDs: A Network... od Felicity Buckley, Axel Finckh, T. Huizinga, F. Dejonckheere, Jeroen P. Jansen
Wydane 2015Revisão -
10
-
11
Anaemia may add information to standardised disease activity assessment to predict radiographic damage in rheumatoid arthritis: a prospective cohort study od Burkhard Möller, Almut Scherer, Frauke Förger, Peter M. Villiger, Axel Finckh
Wydane 2013Artigo -
12
-
13
-
14
Is radiographic progression of late-onset rheumatoid arthritis different from young-onset rheumatoid arthritis? Results from the Swiss prospective observational cohort od R Mueller, T. Kaegi, Axel Finckh, Sarah R. Haile, Hendrik Schulze‐Koops, J. von Kempis
Wydane 2013Artigo -
15
Comparison of drug retention rates and causes of drug discontinuation between anti–tumor necrosis factor agents in rheumatoid arthritis od Sophie Martin Du Pan, Silvia Dehler, Adrian Ciurea, Hans‐Rudolf Ziswiler, Cem Gabay, Axel Finckh
Wydane 2009Artigo -
16
-
17
Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an a... od Axel Finckh, Adrian Ciurea, Laure Brulhart, Burkhard Möller, Ulrich A. Walker, D. Courvoisier, Diego Kyburz, Jean Dudler, Cem Gabay
Wydane 2009Artigo -
18
-
19
-
20
Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis od Matthias Jarlborg, Delphine S. Courvoisier, Céline Lamacchia, Laura Martinez Prat, Michael Mähler, Chelsea Bentow, Axel Finckh, Cem Gabay, Michael J. Nissen
Wydane 2020Artigo
Narzędzie wyszukiwania:
Podobne hasła
Medicine
Internal medicine
Rheumatoid arthritis
Disease
Physical therapy
Immunology
Arthritis
Environmental health
Population
Cohort
Rituximab
Antirheumatic Agents
Observational study
Pathology
Rheumatology
Adalimumab
Adverse effect
Lymphoma
Tofacitinib
Alternative medicine
Biology
Computer science
Etanercept
Gastroenterology
Intensive care medicine
Oncology
Surgery
Abatacept
Clinical trial
Confounding